NextCure to Discuss Innovative Cancer Therapies

TipRanksNov 9 05:50

H.C. Wainwright Maintains NextCure(NXTC.US) With Buy Rating, Cuts Target Price to $4

Futu NewsNov 8 20:35 · Ratings

Optimistic Outlook on NextCure's Strategic Focus on LNCB74 Development

TipRanksNov 8 19:57

Needham Maintains NextCure(NXTC.US) With Buy Rating, Cuts Target Price to $3

Futu NewsNov 8 18:33 · Ratings

NextCure's Strategic Shift and Financial Stability Drive Buy Rating

TipRanksNov 8 18:17 · Ratings

Express News | NextCure Inc : Needham Cuts Target Price to $3 From $4

BreakingsNov 8 18:07